PET/CT Follow up for Head and Neck Squamous Cell Carcinoma
- Status
- RECRUITING
- Phase
- NA
Clinical Trials Related to Head and Neck Squamous Cell Carcinoma
Related studies linked through entity extraction aliases.
3-5 FrAction Stereotactic Body Radiation Therapy for Palliation of Head and Neck Squamous Cell Carcinoma: the FAST Phase II Randomized Trial
- Status
- RECRUITING
- Phase
- PHASE2
Phase I/II Open Label Study Evaluating the Safety and Efficacy of Combining STAT3 Inhibition (TTI-101) With Anti-PD-1 Therapy (Pembrolizumab) in Patients With Recurrent or Metastatic (RM) Head and Neck Squamous Cell Carcinoma (HNSCC)
- Status
- WITHDRAWN
- Phase
- PHASE1/PHASE2
Liquid Biopsy for Early DiagNosis of Squamous Cell Carcinoma of the HeAd and NeCk rEgion
- Status
- RECRUITING
- Phase
- N/A
Study of CHS-114 in Participants With Advanced Solid Tumors
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1
Phase 1, First-in-human, Dose-finding and Expansion Study to Evaluate XmAb®808 in Combination With Pembrolizumab in Advanced Solid Tumors
- Status
- COMPLETED
- Phase
- PHASE1
Autologous T Cells Targeting HPV16 HPV18 & Survivin in Patients With R/R HPV-related Oropharyngeal Cancers
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE1
A Phase 2a, Single-dose, Open-label Study to Evaluate Diagnostic Performance and Safety of Pegsitacianine, an Intraoperative Fluorescence Imaging Agent for the Detection of Cancer, in Patients With Unknown Primary Head and Neck Cancer (ILLUMINATE STUDY)
- Status
- RECRUITING
- Phase
- PHASE2
A Study of TBio-4101 (TIL) and Pembrolizumab in Patients With Advanced Solid Tumors
- Status
- TERMINATED
- Phase
- PHASE1
Study of the Monoclonal Antibody IMT-009 in Patients With Advanced Solid Tumors or Lymphomas
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1/PHASE2
89Zr-girentuximab for PET Imaging of CAIX Positive Solid Tumors
- Status
- TERMINATED
- Phase
- PHASE2
A Study of Vobramitamab Duocarmazine in Participants With Metastatic Castration Resistant Prostate Cancer and Other Solid Tumors
- Status
- TERMINATED
- Phase
- PHASE2
A Study of Decreasing Radiation Therapy and Chemotherapy in People With Head and Neck Cancer
- Status
- RECRUITING
- Phase
- PHASE2
Testing the Safety of Giving a Standard Dose of Radiation Over a Shorter Period of Time for Patients Who Had Surgery for Intermediate-Risk Head and Neck Cancer
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1
A Study of PRT3645 in Participants With Select Advanced or Metastatic Solid Tumors
- Status
- COMPLETED
- Phase
- PHASE1
Dosing Study of Radiation Combined With Tislelizumab and Pamiparib in Patients With Previously Treated Head and Neck Cancer
- Status
- RECRUITING
- Phase
- PHASE1
A Study of Pembrolizumab (MK-3475) With or Without Lenvatinib (E7080/MK-7902) as First Line (1L) Intervention in a Programmed Cell Death-ligand 1 (PD-L1) Selected Population With Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma (R/M HNSCC) (MK-7902-010/LEAP-010)-China Extension
- Status
- COMPLETED
- Phase
- PHASE3
Toripalimab-based Neoadjuvant Therapy in LA-HNSCC
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Neoadjuvant Chemotherapy, Tislelizumab With Afatinib for HNSCC
- Status
- COMPLETED
- Phase
- PHASE2
Real-time Margin Assessment in Head and Neck Cancer
- Status
- COMPLETED
- Phase
- PHASE2